Skip to main content
2024 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Myong-Jin Kim, PharmD (she/her/hers)

Myong-Jin (MJ) Kim serves as a director of Division of Therapeutic Performance II, Office of Research and Standards, Office of Generic Drugs, US Food and Drug Administration. MJ leads the group that leverages expertise in clinical pharmacology, formulation science, and human subject protection to conduct research that ensures therapeutic equivalence of generic versions of oral drug products, and to develop product-specific guidances for generic drug developers. MJ graduated from Georgia Institute of Technology in Atlanta, GA, with a Bachelor of Science in chemistry. Subsequently, she received a Doctor of Pharmacy from the Temple University School of Pharmacy in Philadelphia, PA and completed her postdoctoral training in Clinical Pharmacology at Bassett Healthcare in Cooperstown, NY.

Disclosure information not submitted.

Presentation(s):